Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

AWA Point

Awa Point

Was this the last hurdle for German UPCA Ratification?

By Niklas Mattsson | Posted on July 12, 2021

At the end of 2020, German ratification of the Agreement on a Unified Patent Court (UPCA) looked promising as the German parliament (Bundestag) was approved with the required two-thirds majority. However, two applications before the German Constitutional Court (FCC) for preliminary injunctions against ratification delayed the final steps for the act to be promulgated. This...

Tags: patents, UPC, UPCA

Are companies in control over influencer marketing?

By Sara Söderling | Posted on June 28, 2021

A recent judgement from the Swedish Patent and Market Court of Appeal demonstrates under what conditions an influencer’s posts can be regarded as commercial content and be subject to the Swedish Marketing Act despite not being explicitly included in the agreement between the influencer and the brand owner governing a marketing campaign.    Influencers use...

Tags: advertising, commercial content, influencer, marketing, Swedish Marketing Act

MedTrace receives $30 million investment fuelling US expansion and new business area

By AWA | Posted on May 13, 2021

AWA’s client MedTrace Pharma A/S has received nearly $30 million from Swiss-based Swisscanto Invest and Danish investors ATP and BankInvest. MedTrace has developed a fully automated technology that makes radioactive water clinically available to patients in need of diagnostic heart imaging. Radioactive water (15O-water), currently used on occasion for various scans, will now be produced...

Tags: investment, MedTrace, patents, technology

Lego’s compensation increased tenfold by appeal court

By Ai-Leen Lim | Posted on May 12, 2021

On 1 April 2020 the Guangdong Higher People’s Court announced that it had awarded Danish toymaker Lego Rmb30 million (approximately $4.58 million) in damages for trademark infringement and unfair competition against Guangdong Meizhi Zhijiao Technology Co Ltd and three other defendants. The amount was increased tenfold compared to an earlier decision by the Guangzhou Intellectual...

Tags: china, compensation, Infringement, lego, trademarks

China’s president pledges stronger IP enforcement

By Ai-Leen Lim | Posted on May 4, 2021

China’s president Xi Jinping has reiterated the country’s commitment to strengthening intellectual property protection and enforcement through higher damages and criminalisation. The article was published by the official state-run press agency of the People’s Republic of China – Xinhua. It stresses that innovation is the primary driving force behind development and protecting intellectual property rights is equal to protecting...

Tags: awards, china, copyright, Intellectual Property, Patent, Trademark

The Business of IP – Understanding and Creating Value: Part 3 – Mergers and Collaborations

By Anders Isaksson | Posted on April 20, 2021

In this six-part series, Anders Isaksson explores some of the critical factors and motivators for why companies, small or large, should obtain intellectual property. The aim is to help you understand when and how you can create value from IP, especially when considering a company’s long and short-term goals. In the previous article in this...

Tags: collaborations, due dilligence, Intellectual Property, mergers, patents, trademarks

White Paper – The Business Case for a Circular MedTech Sector

By Mikkel Roed Trier | Posted on April 15, 2021

This whitepaper demonstrates that the efforts of private companies towards circularity can in fact lead to a more sustainable medtech sector. Sustainable solutions in the field have the potential to not only reduce greenhouse gas emissions, but importantly also address a range of issues related to pollution and waste. The effects should benefit natural environments...

Tags: Innovation, medtech, sustainability, White Paper

CellaVision acquires exclusive rights to novel microscopy technology

By AWA | Posted on April 8, 2021

AWA’s client CellaVision has signed an agreement to acquire the exclusive rights to a patent portfolio on Fourier Ptychographic Microscopy, a novel microscopy technology from Clearbridge BioPhotonics. CellaVision is an innovative, global medical technology company that develops and sells leading systems for routine analysis of blood and other body fluids in health care services. AWA...

Tags: CellaVision, due dilligence, patents

EPO releases Patent Index 2020: Applications stable despite pandemic, healthcare innovation soars and the US tops geographic origin of applications outside of Europe

By AWA | Posted on March 18, 2021

The European Patent Office (EPO) released its Patent Index 2020 this week. Despite the coronavirus pandemic, filings remained stable with increases in applications from the medical technology, biotechnology and pharmaceutical industries. These increases helped to counter declines seen in some sectors like mechanical engineering. Top Industries As a result of the current global situation, it...

Tags: EPO, Patent Innovation Index 2020, patents

Recent contributors

Ashley Zhao

Ashley Zhao

Partner, Attorney at Law, Business Area Manager

Alexandre Theodorou

Alexandre Theodorou

Partner, European Patent Attorney

Troels Peter Rørdam

Troels Peter Rørdam

Senior Counsel, European Patent Attorney

Ylva Strandberg

Ylva Strandberg

Counsel, AU and NZ Patent Attorney

Hongyue Li

Hongyue Li

Senior Associate, China Patent Attorney

Laura Stravinskaite

Laura Stravinskaite

Senior Associate, Attorney at Law